Background and Purpose-For years, the relationship between cardiac and neurological ischemic events has been limited to overlapping pathophysiological mechanisms and common risk factors. However, acute stroke may induce dramatic changes in cardiovascular function. The aim of this study was to evaluate how prior cerebrovascular lesions affect myocardial function and signaling in vivo and ex vivo and how they influence cardiac vulnerability to ischemia-reperfusion injury. Methods-Cerebral embolization was performed in adult Wistar male rats through the injection of microspheres into the left or right internal carotid artery. Stroke lesions were evaluated by microsphere counting, tissue staining, and assessment of neurological deficit 2 hours, 24 hours, and 7 days after surgery. Cardiac function was evaluated in vivo by echocardiography and ex vivo in isolated perfused hearts. Heart vulnerability to ischemia-reperfusion injury was investigated ex vivo at different times post-embolization and with varying degrees of myocardial ischemia. Left ventricles (LVs) were analyzed with Western blotting and quantitative real-time polymerase chain reaction. Results-Our stroke model produced large cerebral infarcts with severe neurological deficit. Cardiac contractile dysfunction was observed with an early but persistent reduction of LV fractional shortening in vivo and of LV developed pressure ex vivo. Moreover, after 20 or 30 minutes of global cardiac ischemia, recovery of contractile function was poorer with impaired LV developed pressure and relaxation during reperfusion in both stroke groups. Following stroke, circulating levels of catecholamines and GDF15 (growth differentiation factor 15) increased. Cerebral embolization altered nitrooxidative stress signaling and impaired the myocardial expression of ADRB1 (adrenoceptor β1) and cardioprotective Survivor Activating Factor Enhancement signaling pathways. Conclusions-Our findings indicate that stroke not only impairs cardiac contractility but also worsens myocardial vulnerability to ischemia. The underlying molecular mechanisms of stroke-induced myocardial alterations after cerebral embolization remain to be established, insofar as they may involve the sympathetic nervous system and nitro-oxidative stress. Visual Overview-An online visual overview is available for this article.
C ardiovascular and cerebrovascular diseases share several pathophysiological mechanisms and risk factors, and they remain among the leading causes of death and medical spending worldwide. While it is well documented that cardiac diseases such as atrial fibrillation 1, 2 or acute myocardial infarction 3 (AMI) may favor the occurrence of ischemic stroke (IS), some clinical data also suggest that acute cerebral ischemic events may in turn induce dramatic shifts in cardiovascular function. 4 For instance, Takotsubo cardiomyopathy may occur in the days after an IS. 5 Furthermore, it has been shown that ischemic lesions in specific brain regions such as the insular cortex are associated with cardiac dysfunction and sudden cardiac death. 6 Indeed, even in the absence of documented preliminary heart disease, myocardial dysfunction is commonly encountered in stroke patients. [7] [8] [9] [10] Cardiovascular complications after stroke are the second cause of death after the direct consequences of neurological damage. 11, 12 Moreover, a significant proportion of patients with IS display elevated levels of cardiac troponins, 7, 13, 14 relevant markers of myocardial damage, though half of them show no angiographic evidence of coronary artery disease. 15 Therefore, the possibility of stroke-induced myocardial dysfunction/injury needs to be investigated more thoroughly.
In experimental studies, a link has been established between brain damage and cardiac disorders. For instance, several studies have shown that middle cerebral artery occlusion (MCAO) could impair calcium and other ionic currents in ventricular cardiomyocytes, thus inducing arrhythmia in rats, 16, 17 and may also lead to cardiac contractile dysfunction in mice. 18 Another study further suggests that ischemic brain tissues send death signals to the heart. 19 Recently, it has been proposed that circulating components might directly be involved in cerebral ischemia-induced cardiac dysfunction such as MiR-126 20 or catecholamines. 21 However, to date, no work has extensively explored the potential vulnerability to myocardial ischemia/infarction associated with prior IS.
Therefore, it seems essential to evaluate how prior cerebral ischemia could alter cardiac function and its subsequent adaptation to ischemic stress, and which cardiac cellular signaling pathways involved in cardioprotection are impaired. The aim of this study was thus to mimic a situation of embolic stroke and to evaluate how cerebrovascular lesions may affect the heart functions at the in vivo, ex vivo, and cellular level.
Methods
This article adheres to the American Heart Association Journals implementation of the Transparency and Openness Promotion Guidelines. Details of materials and methods are available in the online-only Data Supplement. Data that support the findings of this study are available from the corresponding author on reasonable request.
Animals
Wistar male rats (Charles River, Ecully, France; 8-9 weeks, 300±50 g) were used. All animals received humane care and study protocols complied with institutional guidelines. The investigation was performed in accordance with Directive 2010/63/EU of the European Parliament and to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No 85-23, revised 1996) and was approved by the local ethics committee (Comité d'Ethique de l'Expérimentation Animale Université-Bourgogne-Franche-Comté, Dijon, France, protocol agreement number: 0412.01). The animals were housed at 21±2°C with a constant humidity of 55±10% under a cycle of 12 hour of light/ dark and had free access to water and standard diet ad libitum.
Model of Cerebral Embolization
Polystyrene microspheres (90 μm; Polysciences, Inc, Warrington) were used for cerebral embolization. The solution was diluted so as to inject around 4000 microspheres in 200 μL of 20% polyvinylpyrrolidone in the internal carotid artery. A detailed description of surgical procedure is available in the online-only Data Supplement.
Neurological Deficit Assessment and Determination of Cerebral Embolization and Infarct Size
Neurological deficit was assessed 2 hours, 24 hours, or 7 days after surgery using a modified scoring system developed by Longa et al 22 by an observer blinded to the animal groups. Deficits were scored as follows: 0, no deficits; 1, failure to extend contralateral forepaw fully; 2, circling to contralateral side without falling; 3, falling to contralateral side; and 4, no spontaneous motor activity. Higher scores represent more severe motion impairment. A detailed description of cerebral embolization determination and infarct size measurement are available in the online-only Data Supplement.
Assessment of Cardiac Function In Vivo With Echocardiography
Transthoracic echocardiography using the Vevo770 imaging system (VisualSonics Inc, Toronto, Canada) equipped with a 25 MHz probe was performed 7 days before surgery, 2 hours, 24 hours, and 7 days after surgery in rats as previously described, 23 and detailed in the online-only Data Supplement.
Assessment of Cardiac Function Ex Vivo
Two or 24 hours after cerebral embolization, rats were deeply anesthetized through an intraperitoneal injection of 110 mg/kg sodium pentobarbital, and the blood clotting was avoided by the co-administration of 500 IU/kg of heparin. After total loss of nociception, the chest was opened and the heart was excised and placed in a cold (4°C) perfusion buffer bath until contractions ceased. The heart was then immediately cannulated through the aorta and perfused according to the Langendorff method as previously described 24 and detailed in the online-only Data Supplement.
Measurement of Myocardial Vulnerability to Ischemia-Reperfusion Injury Ex Vivo
After baseline measurements, perfusion was turned off so as to induce 20 or 30 minutes of total global normothermic ischemia, which was followed by 1 hour of reperfusion. All parameters were recorded during ischemia and reperfusion.
Determination of Plasma Epinephrine, Norepinephrine, and Growth Differentiation Factor 15
Blood was collected from the abdominal aorta, and immediately centrifuged at 4°C to separate the plasma, and samples were stored at −80°C. Plasma epinephrine and norepinephrine levels were measured using the 2-CAT (A-N) Research ELISA kit (BA E-5400; Labor Diagnostika Nord, Nordhorn, Germany) following the manufacturer's protocol. Plasma GDF15 (growth differentiation factor 15) was measured using a commercially available kit (MGD150, R&D systems, MN).
Quantitative Real-Time Polymerase Chain Reaction
Semiquantitative analysis of eNOS (endothelial nitric oxide synthase), GPX1 (glutathione peroxidase 1), CAT (catalase), ADRB1 (adrenoceptor β1), JAK2 (janus kinase 2), and STAT3 (signal transducer and activator of transcription 3) were performed, and the procedure is detailed in the online-only Data Supplement.
Western Blotting
Ventricular tissue was homogenized in 10 volumes radio-immunoprecipitation assay buffer, centrifuged at 10 000 g for 15 minutes at 4°C, and protein concentration (Lowry method) was determined in supernatant. Protein expressions were evaluated by Western blotting, and detailed procedures are available in the online-only Data Supplement.
Statistics
Data are presented as mean±SEM. The statistically significant differences for mean values of 3 groups were tested by analysis of variance followed by Tukey's test. An analysis of variance for repeated measurements followed by a Tukey post hoc analysis was applied for data consisting of repeated observations at successive time points. The difference was considered significant when P<0.05. The data were analyzed using SigmaPlot version 12.5.
Results

Cerebral Embolization With Microspheres Leads to Large Stroke Infarcts and Neurological Deficit
Severe neurological deficit scores were observed in all stroke groups 2 hours, 24 hours, and 7 days after embolization ( Figure  I in the online-only Data Supplement). Two hours after embolization, 397±33 microspheres were found in the ipsilateral
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hemisphere and 54±5 in the contralateral hemisphere. 2,3,5-triphenyl-tetrazolium chloride staining was performed in brain slices 24 hours after embolization. Sham-operated rats showed uniform red coloration of viable gray matter cell-containing areas and white staining of acellular white matter fibers (corpus callosum, internal capsule). In embolized rats, white necrotic areas were only observed in the ipsilateral hemisphere. Stroke volumes were 31±4% for the left ventricle (LV) and 29±4% for the right ventricle 24 hours after embolization.
Cerebral Embolization Leads to Cardiac Dysfunction Ex Vivo and In Vivo
Cardiovascular function was initially assessed in vivo. There were no statistically significant differences between the 3 groups concerning arterial systolic blood pressure ( Figure 1A ). We found an early (from H2) and persistent (until D7) deterioration in LV fractional shortening during the 7-day follow-up period in both stroke versus sham groups ( Figure 1B) . Then, to evaluate poststroke cardiac function independently of any circulating and/or nervous influencing factors, we isolated and perfused the rat hearts ex vivo and measured left ventricular functional parameters. Two hours after cerebral embolization, the baseline LV developed pressure was significantly lower in both groups of stroke rats than in the sham group: 106.6±4.4 mm Hg (left), 106.2±4.7 mm Hg (right) versus 129.9±2.7 mm Hg (sham; Figure 1C Figure 1D ). The other functional parameters were similar for the 3 groups during basal perfusion.
Cerebral Embolization Increases Cardiac Vulnerability to Ischemia-Reperfusion Injury Ex Vivo
To evaluate how prior IS may influence myocardial vulnerability to ischemia-reperfusion (IR) injury, we exposed hearts isolated 2 hours after cerebral embolization to 30 minutes of global total ischemia, which is generally considered as partially irreversible. Reperfusion led to only limited recovery of the initial cardiac functional parameters. In the right stroke group, the post-ischemic recovery of coronary flow was significantly lower than that in the sham group: 8.3±0.1 mL/min versus 10.6±0.2 mL/min, respectively, P<0.05 (Figure 2A ). During ischemia, the heart stopped beating, but an increase in LV diastolic pressure because of ischemic contracture was observed in both groups. Reperfusion led to an abrupt and sharp increase in LV diastolic pressure, related to post-ischemic contracture that was even higher in the right stroke group than that in the sham group from the 20th minute of reperfusion: 90.6±4.2 mm Hg versus 72.6±4.3 mm Hg, respectively, P<0.05 ( Figure 2B ). After 30 min of global total ischemia, reperfusion led to only a partial recovery of myocardial contractility in all groups, with identical return to an altered sinus rhythm (data not shown). However, the LV developed pressure and −dP/dt were significantly lower in both right and left stroke groups than in the sham group after 60 minutes of reperfusion ( Figure 2C and 2D) .
In a second set of experiments, we evaluated the myocardial vulnerability to a more reversible IR injury and subjected isolated hearts to 20 minutes of global total ischemia followed 
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by reperfusion. In these conditions, all 3 groups recovered total coronary flow with hyperemia during the 20 first minutes of reperfusion ( Figure 3A) . However, concerning cardiac contractility, HR, LV developed pressure, and −dP/dt recovered significantly more slowly during reperfusion in both stroke groups than in the sham group ( Figure 3B , 3C, and 3D). Myocardial recovery after IR injury was also evaluated 24 hours after stroke or sham embolization ( Figure II in the online-only Data Supplement). However, unattended nearly total recovery of all functional parameters was observed in sham groups, as compared to the same duration of cardiac ischemia in hearts harvested 2 hours after microsphere embolization or sham-surgery under isoflurane anesthesia. In these very different conditions, post-ischemic recovery of myocardial functional parameters did not differ between groups, except for HR or LV developed pressure in left stroke hearts at certain points in time.
Cardiac Dysfunction After Cerebral Embolization Is Associated With Increased Catecholamine and GDF15 Levels in Circulation
To evaluate the activation of the autonomic nervous system, we assessed plasma concentration of catecholamines. At 2 and 24 hours after embolization, both stroke groups showed a significant increase in plasma epinephrine and norepinephrine as compared to sham-operated rats ( Figure 4A and 4B) .
GDF15, a marker of several conditions including cardiovascular disease, was circulating at higher levels 2 hours after cerebral embolization in both groups of stroke rats than in the sham group ( Figure 4C Figure 4D ).
Cerebral Embolization Alters Nitro-Oxidative Signaling in the Heart
To examine the potential impact of stroke on myocardial cellular signaling, genes and proteins involved in nitro-oxidative stress were assed in the myocardium. Left or right cerebral embolization significantly increased the cardiac expression of eNOS and GPX1 in mRNA and protein and decreased protein expression of phosphorylated eNOS. CAT protein expression was decreased in the hearts of left or right stroke rats without modifications of the mRNA levels ( Figure 5 ; Figure III in the online-only Data Supplement).
Cerebral Embolization Impaired Myocardial Expression of ADRB1 and Cardioprotective Survivor Activating Factor Enhancement Signaling Pathway
The expression of the main cardiac adrenergic receptor, ADRB1, was investigated to evaluate the potential mechanism of stroke-induced myocardial contractile dysfunction, despite increased circulating epinephrine and norepinephrine levels. The results showed decreased protein expression of ADRB1 ( Figure 6A ).
So as to understand how prior cerebral infarction was able to worsen myocardial functional recovery after either reversible or irreversible cardiac ischemic injury, members of the Survivor Activating Factor Enhancement (SAFE) cardioprotective signaling pathway were assessed in the myocardium. The results showed that left or right cerebral embolization significantly decreased short-term cardiac expression of JAK2, STAT3, and phosphorylated STAT3 in protein ( Figure 6 ).
Discussion
In the present study, we show for the first time that prior cerebral ischemia in rats can increase myocardial vulnerability to IR injury and alter cellular signaling in the genes and proteins generally considered as providing cardioprotection, such as endothelial nitric oxide synthase and members of the SAFE pathway. We have also highlighted a change in cardiac contractile function both in vivo and ex vivo, the latter being observed in a situation where neither circulating factors nor nervous control could influence cardiac function, suggesting that stroke has a persisting imprinting effect on heart tissue. Sympathetic hyperactivity with a rise of circulating catecholamines, as opposed to a downregulation of cardiac ADRB1 protein, could be considered as one of the potential mechanisms of stroke-driven cardiovascular deleterious effects.
The model of cerebral embolization with microsphere injection into the internal carotid artery was chosen because it may reproduce some aspects of embolic strokes of cardiac or carotid origin. 25 One limitation of this model is that microspheres are randomly distributed throughout the brain and produce disseminated infarcts, as opposed to conventional MCAO for which stroke volume and location in specific areas of the brain can be evaluated. In fact, it could be interesting to induce damage in defined brain regions such as the insular cortex, the activation of which leads to cardiovascular consequences. 6 Finally, the microsphere embolization model induces nonreversible artery occlusion and produces the creation of small permanent cerebral infarcts, 26 while in stroke patients reperfusion can occur spontaneously or be clinically induced by thrombolysis. However, the majority of patients with large vessel stroke do not have recanalization 27 ; our model may therefore be appropriate for preclinical evaluation of large vessel occlusion.
Brain-heart interactions after stroke have been observed in several clinical and animal studies, and recent data further suggest that aging, hypertension, and diabetes mellitus contribute to distinctly affect microvessels gene network in these 2 organs. 28 Indeed, atrial fibrillation may occur after an IS 29 : in the 3 months after an IS, 19% of patients experience serious cardiac adverse events 12 and 6.5% of patients develop AMI or acute heart failure. 30 From an experimental point of view, in vivo studies have shown that cerebral injuries can induce severe cardiac arrhythmia, myocardial dysfunction, and even cardiomyocyte necrosis. 18, 31 Experiments performed ex vivo have shown that cardiomyocytes isolated from the hearts of right MCAO rats displayed longer action potential duration. 17, 31 In our study, IS involved the insular cortex which may have had an impact on cardiac function in vivo (see Figure 2) . One of the striking observations of our work is that prior IS was not only able to decrease LV contractility in vivo, but also ex vivo in isolated perfused hearts, where neither circulating nor nervous factors influence cardiovascular function. This observation is remarkable because it suggests that cerebral ischemia has a persistent impact on the heart through signals 
Stroke
that affect its function in addition to direct endocrine and/or neuronal effect and that this retained effect occurs as early as 2 hours after embolization. Our findings therefore corroborate other studies showing that MCAO in rats was able to impact the calcium currents and channels of the cardiomyocyte, as well as other ionic currents and proteins involved in the action potential 17, 31 or in the cardiac excitation-contraction coupling. 16 Another original result of the present study is that prior cerebral ischemia is able to increase myocardial vulnerability to IR injury ex vivo. Indeed, we found a negative impact of cerebral embolization on functional recovery of isolated hearts after either reversible or irreversible total global ischemia. The deleterious effect of stroke is clear 2 hours after surgery but is partially hidden after a longer lapse of time (24 hours), probably because of the delayed preconditioning effect of both isoflurane anesthesia and the surgical procedure. The observation that prior cerebral ischemia may worsen myocardial post-ischemic recovery can be regarded as paradoxical in view of the well-known concept of remote ischemic conditioning, by which ischemia to a distant organ may protect the heart against AMI. When extended to the clinical situation, these results may raise the question of whether stroke patients have increased vulnerability to AMI. Our results may therefore corroborate data showing that patients who developed an AMI after an IS had an increased mortality rate versus the general population. 30 We also observed that right hemispheric strokes were more damaging for cardiac function and post-ischemic recovery than left hemispheric strokes. In fact, it has been shown both in humans and in experimental studies that a lateralization exists concerning cardiac effects of cerebral ischemia, which is related to that distinct areas in the left or right brain insula control either the sympathetic or the parasympathetic autonomic nervous system. 32 Indeed, several studies have shown that right stroke begets more cardiovascular effects such as arrhythmias or increased myocardial damage confirmed by elevated troponin levels. 21, 31, 33 It has been proposed that rightsided insular cortex regulates sympathetic tone, whereas left controls parasympathetic. Vascular damage in right hemisphere involves a downregulation of parasympathetic activity with an upregulation of the sympathetic consequence on cardiac function. 33 However, the microsphere embolization model used in the present study, as stated before, does not allow for a study of the impact of revascularization on stroke-induced cardiac effects. Future studies with a model allowing both reperfusion, damage in selective brain regions, and different stroke durations such as the MCAO model are planned, so as to determine whether the myocardial ischemic vulnerability after an IS persists when the brain is reperfused and if the cardiac impact of cerebral ischemia is still present at a later time after stroke.
Following these observations, we aimed to determine which cardiac cellular pathways could be modified by prior stroke and thus could be involved in these stroke-induced alterations of myocardial function. It is well known that stroke is associated with an activation of the sympathetic nervous system, which is consistent with our data showing increased catecholamine levels in stroke groups. 18, 21 It has been shown that β1-blocker treatment in stroke mice improved cardiac function and decreased catecholamine levels 2 months after IS and had neuroprotective effects over the 7-day follow-up period. 21, 34 In the present study, a downregulation of ADRB1 was observed in hearts 2 hours after embolization, which could be a result of post-translational regulating systems. GDF15 levels were also increased in stroke rats 2 and 24 hours after embolization as compared to sham groups. It has been shown that GDF15 levels were significantly increased in patients with IS and even more when stroke involved large arteries. Indeed, GDF15 gene polymorphism may play a role in the development of IS. 35 Concomitantly to IS, several neurohumoral systems, including inflammatory cytokines, are activated, and recent data have shown that chronic inflammation may propagate from the ischemic cerebellum to distant peripheral organs such as the heart. 36 The occurrence of a nitro-oxidative stress could also be involved in these brain-heart interactions, which has been shown after transient MCAO in rats. 37 The increased gene and protein expression of GPX1 should be opposed to decrease in CAT which has an 8-fold higher activity than GPX1 in humans. 38 Additionally, it has been shown that some cardioprotective molecular pathways could be recruited by the cardiac tissue to fight the damaging effects of ischemia reperfusion injury. 39 Taking into consideration the idea that prior stroke impaired post-ischemic cardiac recovery, we hypothesized that some members of the cardioprotective pathways might have been altered after cerebral ischemia. In fact, JAK2, STAT3, and phosphorylated STAT3 protein expression, all members of the SAFE cardioprotective signaling pathway, decreased in the heart 2 hours after cerebral embolization. Therefore, the increased vulnerability of the heart to ischemia reperfusion injury after stroke might be, at least in part, related to an impairment of the SAFE signaling pathway. An upregulation or a pharmacological induction of these signaling pathways could therefore be used as therapeutic target to protect the heart after IS.
Conclusions
These original data indicate not only that, in a model of cerebral embolization in rats, stroke deleteriously impairs cardiac contractility but also worsens myocardial vulnerability to ischemia. At the molecular level, we highlighted sympathetic hyperactivity, a disturbance of nitro-oxidative regulators in the heart, and impairment of the cardioprotective SAFE signaling pathway. The underlying molecular mechanisms of the stroke-induced myocardial alterations after cerebral embolization remain to be established, insofar as they may involve the sympathetic nervous system or and nitro-oxidative stress. From a clinical point of view, these results may be of major importance for the management of stroke patients, to protect the heart after cerebral ischemia.
